Skip to main content

Table 3 Comparison of results obtained by different methods for equivocal cases (n = 29)

From: Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens

Manual scoring

Tile-sampling analysis

Nuclei-sampling analysis, after human correction

< 1.8

≥ 1.8 – < 2.0

2.0 – 2.2

> 2.2

< 1.8

≥ 1.8 – < 2.0

2.0 – 2.2

> 2.2

≥ 1.8 - < 2.0

12

1

1

0

7

5

1

1

2.0 – 2.2

7

5

2

1

4

5

6

0